Last update 21 Nov 2024

Soquelitinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Mechanism
ITK inhibitors(Tyrosine-protein kinase ITK/TSK inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC25H30N4O4S2
InChIKeyKNCWSXRTKLTULH-MRXNPFEDSA-N
CAS Registry2226636-04-8

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anaplastic Large-Cell LymphomaPhase 3
US
02 Oct 2024
Follicular LymphomaPhase 3
US
02 Oct 2024
Follicular T-cell lymphomaPhase 3
US
02 Oct 2024
Immunoblastic LymphadenopathyPhase 3
US
02 Oct 2024
Peripheral T-Cell LymphomaPhase 3
US
02 Oct 2024
T-Cell LymphomaPhase 1
CN
17 Dec 2021
T-cell lymphoma recurrentPhase 1
KR
03 May 2019
T-cell lymphoma recurrentPhase 1
US
03 May 2019
T-cell lymphoma recurrentPhase 1
AU
03 May 2019
T-cell lymphoma recurrentPhase 1
CN
03 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
23
(jdinphwani) = hlydftonjn bhlexuoift (pjdtcztfcs )
Positive
06 May 2024
Phase 1
36
(jyytkxbqkv) = hvzpogccja sbznsskokd (fiairoitjy )
Positive
09 Dec 2023
(≥1 to ≤ 3 therapies)
(jgilutacnr) = bijtnmbnad pxcvgnprpl (ssoewwwzri )
Phase 1
3
(vdodrdlfpk) = soquelitinib induced normal CD4+ Th1 cells and CD8+ TEMRA cells and reduced CD4+ Treg cells in the tumor microenvironment in responding patients. vsxgndnzto (icnkigvfzt )
Positive
09 Dec 2023
Phase 1
43
(kktaadosrn) = jaccygxpck fnqpobcjqs (rccdcduyrq )
Positive
12 Dec 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free